摘要
目的：探讨冠状动脉介入术患者对比剂肾病的发病危险因素。方法：收集我院2010年03月～2011年10月期间住院的360例接受冠状动脉介入术患者的临床资料，以血肌酐为标准，测定介入治疗前后血清肌酐，分析发生对比剂肾病危险因素。结果：360例患者发生对比剂肾病28例，发生率7．71％（28／360），Logistic回归分析发现：吸烟支年、对比剂用量、遗传、高血压病、糖尿病、干预方法有统计学意义（P〈0．05），即上述因素与CIN的发病密切相关。而性别、病变支数、LDL、尿酸与CIN的发病无明显相关关系。结论：CIN的发生危险因素包括吸烟支年、对比剂用量、遗传、高血压病、糖尿病、干预方法等。
Objective：Aim to investigate the risk factors of contrast -induced Nephropathy（CIN） in the percutaneous coronary inter- vention （PCI）. Methods：To collect the clinical data of 360 patients who underwent the PCI from March,2010 to November, 2011, In or- der to serum creatinine as a standard, recorded the creatinine（Cre） before and after treatment, and analyse the risk factors for occurrence of CIN. Results： The incidence of serum creatinine - based CIN was7.78 % （28/360） in all. Risk factors Analysis ： smoking variables of years, contrast agent dosage, genetic, hypertension, diabetes, intervention methods are statistically significant. But sex, lesion count, LDL, uric acid do not show statistically significant differences. Conclusion： The occurrence of CIN is closely associated with risk factors. such as smoking, contrast agent dosage, genetic, hypertension, diabetes, intervention methods and CIN.
出处
《中国伤残医学》
2013年第11期35-37,共3页
Chinese Journal of Trauma and Disability Medicine
基金
山东省济宁市科技计划项目
关键词
对比剂肾病
危险因素
冠状动脉介入术
Contrast induced nephropathy
Risk factors
Percutaneous coronary intervention
